Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BH3I-1 (BHI1) 是一种Bcl-2家族拮抗剂,作用于p53/mDM2,Kd 为 5.3 μM。它抑制BakBH3 肽与Bcl-xL 结合,Ki 为 2.6 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 233 | 现货 | ||
2 mg | ¥ 329 | 现货 | ||
5 mg | ¥ 538 | 现货 | ||
10 mg | ¥ 872 | 现货 | ||
25 mg | ¥ 1,620 | 现货 | ||
50 mg | ¥ 2,660 | 现货 | ||
100 mg | ¥ 4,320 | 现货 |
产品描述 | BH3I-1 (BHI1) is a Bcl-2 antagonist. |
靶点活性 | BH3-BCL XL:2.4 μM(Ki), MDM2-p53:5.3 μM(Kd) |
体外活性 | BH3I-1 inhibits Bcl-xL heterodimerization in vitro. It also induces cytochrome c release[1]. BH3I-1, while inhibiting its reported target Bcl-2/Bim and Bcl-xL/Bim, shows significant inhibition of both the p53/hDM2 and p300/Hif-1a interactions[2]. |
细胞实验 | Cells (5×104 cells per well) are seeded into white 96-well plates (Costar) and treated with various concentrations of the compounds for 48 h. For zVAD-FMK protection experiments, cells are preincubated with 100 μM zVAD-FMK for 1 h before the addition of chemicals. Cell viability is determined with an MTS assay. For PI staining experiments, cells are grown in 24-well plates and then incubated with 2 μg ml/L PI. Cell death is determined by FACS analysis.(Only for Reference) |
别名 | BHI1 |
分子量 | 400.31 |
分子式 | C15H14BrNO3S2 |
CAS No. | 300817-68-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 60 mg/mL (149.9 mM)
Ethanol: 11 mg/mL (27.5 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.4981 mL | 12.4903 mL | 24.9806 mL | 62.4516 mL |
5 mM | 0.4996 mL | 2.4981 mL | 4.9961 mL | 12.4903 mL | |
10 mM | 0.2498 mL | 1.249 mL | 2.4981 mL | 6.2452 mL | |
20 mM | 0.1249 mL | 0.6245 mL | 1.249 mL | 3.1226 mL | |
DMSO | 50 mM | 0.05 mL | 0.2498 mL | 0.4996 mL | 1.249 mL |
100 mM | 0.025 mL | 0.1249 mL | 0.2498 mL | 0.6245 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BH3I-1 300817-68-9 Apoptosis Ubiquitination E1/E2/E3 Enzyme BCL MDM-2/p53 BH3I 1 BHI-1 Inhibitor Ubiquitin ligase E3 ligating enzyme Ubiquitin conjugating enzyme BH3I1 E2 conjugating enzyme Bcl-2 Family BHI1 E1 activating enzyme inhibit BH 3I1 BHI 1 Ubiquitin activating enzyme BH-3I-1 inhibitor